» Articles » PMID: 14735402

Quantitation of Human Immunodeficiency Virus Type 1 RNA Loads in Cervicovaginal Secretions in Pregnant Women and Relationship Between Viral Loads in the Genital Tract and Blood

Overview
Publisher Springer
Date 2004 Jan 22
PMID 14735402
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to analyze the quantitation of the human immunodeficiency virus type 1 RNA (HIV-1 RNA) in the genital tract of HIV-1-infected pregnant women and to evaluate a possible correlation with the viral load in blood plasma (Spearman's rank correlation coefficient). A total of 38 each of cervical, vaginal, and blood samples from 38 women were obtained during the third trimester of pregnancy for quantitation of the HIV-1 RNA load. Viral loads were determined by reverse transcription-polymerase chain reaction. The HIV-1 RNA viral load was detectable in 29 of the 38 (76.3%) blood samples, in 6 of the 38 (15.7%) cervical secretion samples, and in 8 of the 38 (21%) vaginal secretion samples. Overall, the correlation between the HIV-1 RNA viral load in the blood plasma and in cervical secretion samples was 0.51 ( P<0.001). However, the correlation disappeared ( r=0.27) when three patients with high blood plasma viral loads were eliminated from the statistical study. The viral load in the vaginal secretions did not correlate with that in the blood samples ( r=0.26). There were two cases in which HIV-1 RNA was undetectable in the blood and cervix but was detectable in vaginal secretions: one woman had 220 copies/ml and the other 68 copies/ml. These results suggest that pregnant women with undetectable viral loads in blood plasma are still at risk of transmitting the virus vertically during vaginal delivery. Because of this, antiretroviral prophylaxis during vaginal delivery must be administered to HIV-1-infected women and their newborns, regardless of the mother's viral load in plasma. In conclusion, quantification of cervicovaginal levels of HIV-1 may represent a useful tool for assessing the individual risk associated with a vaginal delivery and for guiding decisions about whether a scheduled caesarean should be recommended.

Citing Articles

Brief Report: Vaginal Viral Shedding With Undetectable Plasma HIV Viral Load in Pregnant Women Receiving 2 Different Antiretroviral Regimens: A Randomized Clinical Trial.

Frenkel L, Morrison R, Fuller T, Gouvea M, Benamor Teixeira M, Coombs R J Acquir Immune Defic Syndr. 2021; 88(4):361-365.

PMID: 34369908 PMC: 8547747. DOI: 10.1097/QAI.0000000000002771.


Rilpivirine Plasma and Cervicovaginal Concentrations in Women During Pregnancy and Postpartum.

Eke A, Chakhtoura N, Kashuba A, Best B, Sykes C, Wang J J Acquir Immune Defic Syndr. 2018; 78(3):308-313.

PMID: 29528944 PMC: 6002878. DOI: 10.1097/QAI.0000000000001677.


Estimating PMTCT's Impact on Heterosexual HIV Transmission: A Mathematical Modeling Analysis.

Khanna A, Roberts S, Cassels S, Ying R, John-Stewart G, Goodreau S PLoS One. 2015; 10(8):e0134271.

PMID: 26262889 PMC: 4532442. DOI: 10.1371/journal.pone.0134271.


The effects of chronic binge alcohol on the genital microenvironment of simian immunodeficiency virus-infected female rhesus macaques.

Loganantharaj N, Nichols W, Bagby G, Volaufova J, Dufour J, Martin D AIDS Res Hum Retroviruses. 2014; 30(8):783-91.

PMID: 24902876 PMC: 4118703. DOI: 10.1089/AID.2014.0065.


Antiretroviral treatment, viral load of mothers & perinatal HIV transmission in Mumbai, India.

Ahir S, Chavan V, Kerkar S, Samant-Mavani P, Nanavati R, Mehta P Indian J Med Res. 2013; 138:201-8.

PMID: 24056596 PMC: 3788205.


References
1.
Shaheen F, Sison A, McIntosh L, Mukhtar M, Pomerantz R . Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women. J Hum Virol. 1999; 2(3):154-66. View

2.
Garcia P, Kalish L, Pitt J, Minkoff H, Quinn T, Burchett S . Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med. 1999; 341(6):394-402. DOI: 10.1056/NEJM199908053410602. View

3.
Iribarren J, Ramos J, Guerra L, Coll O, de Jose M, Domingo P . [Prevention of vertical transmission and treatment of infection caused by the human immunodeficiency virus in the pregnant woman. Recommendations of the Study Group for AIDS, Infectious Diseases, and Clinical Microbiology, the Spanish Pediatric...]. Enferm Infecc Microbiol Clin. 2001; 19(7):314-35. DOI: 10.1016/s0213-005x(01)72652-3. View

4.
Si-Mohamed A, Andreoletti L, Colombet I, CARRENO M, Lopez G, Chatelier G . Quantitation of human immunodeficiency virus type 1 (HIV-1) RNA in cell-free cervicovaginal secretions: comparison of reverse transcription-PCR amplification (AMPLICOR HIV-A MONITOR 1.5) with enhanced-sensitivity branched-DNA assay (Quantiplex 3.0). J Clin Microbiol. 2001; 39(6):2055-9. PMC: 88088. DOI: 10.1128/JCM.39.6.2055-2059.2001. View

5.
Gaillard P, Verhofstede C, Mwanyumba F, Claeys P, Chohan V, Mandaliya K . Exposure to HIV-1 during delivery and mother-to-child transmission. AIDS. 2000; 14(15):2341-8. DOI: 10.1097/00002030-200010200-00015. View